GBT insider transactions
Global Blood Therapeutics Inc. (GBT) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for GBT
- SEC Form 4: Patrick Deval L returned 9,037 shares to the company, closing all direct ownership in the company to cover withholding tax4 - Global Blood Therapeutics, Inc. (0001629137) (Issuer)
- SEC Form 4: Thompson Alexis A. returned 3,308 shares to the company, closing all direct ownership in the company to satisfy tax liability4 - Global Blood Therapeutics, Inc. (0001629137) (Issuer)
- SEC Form 4: Morrison Scott W returned 6,637 shares to the company, closing all direct ownership in the company (tax withholding)4 - Global Blood Therapeutics, Inc. (0001629137) (Issuer)
- SEC Form 4: Perry Mark L returned 37,865 shares to the company, closing all direct ownership in the company to satisfy withholding tax4 - Global Blood Therapeutics, Inc. (0001629137) (Issuer)
- SEC Form 4: Yarno Wendy L returned 11,437 shares to the company, closing all direct ownership in the company (withholding obligation)4 - Global Blood Therapeutics, Inc. (0001629137) (Issuer)
- SEC Form 4: Svoronos Dawn returned 5,376 shares to the company, closing all direct ownership in the company to satisfy withholding obligation4 - Global Blood Therapeutics, Inc. (0001629137) (Issuer)
- SEC Form 4: Pizzo Philip A. returned 9,112 shares to the company, closing all direct ownership in the company (withholding tax)4 - Global Blood Therapeutics, Inc. (0001629137) (Issuer)
- SEC Form 4: Pierce Glenn returned 26,437 shares to the company, closing all direct ownership in the company to satisfy withholding obligation4 - Global Blood Therapeutics, Inc. (0001629137) (Issuer)
- SEC Form 4: Johnson David Lee gifted 22,000 shares and returned 34,384 shares to the company, closing all direct ownership in the company (withholding obligation)4 - Global Blood Therapeutics, Inc. (0001629137) (Issuer)
- SEC Form 4: Smith-Whitley Kim returned 5,980 shares to the company, closing all direct ownership in the company to satisfy withholding obligation4 - Global Blood Therapeutics, Inc. (0001629137) (Issuer)
- SEC Form 4: Krehlik Carrie returned 6,716 shares to the company, closing all direct ownership in the company (withholding tax)4 - Global Blood Therapeutics, Inc. (0001629137) (Issuer)
- SEC Form 4: Habibizad Nazila returned 39,680 shares to the company, closing all direct ownership in the company (for withholding tax)4 - Global Blood Therapeutics, Inc. (0001629137) (Issuer)
- SEC Form 4: Love Ted W returned 922,618 shares to the company, closing all direct ownership in the company to satisfy withholding obligation4 - Global Blood Therapeutics, Inc. (0001629137) (Issuer)
- SEC Form 4: Choi Jung returned 251,672 shares to the company, closing all direct ownership in the company to cover withholding tax4 - Global Blood Therapeutics, Inc. (0001629137) (Issuer)
- SEC Form 4: Farrow Jeffrey S returned 26,739 shares to the company, closing all direct ownership in the company to satisfy withholding tax4 - Global Blood Therapeutics, Inc. (0001629137) (Issuer)
- SEC Form 4: Suvari Tricia Borga returned 43,077 shares to the company, closing all direct ownership in the company to cover taxes4 - Global Blood Therapeutics, Inc. (0001629137) (Issuer)
- SEC Form 4: Habibizad Nazila gifted 3,500 shares and converted options into 1,557 shares, decreasing direct ownership by 5% to 39,680 units4 - Global Blood Therapeutics, Inc. (0001629137) (Issuer)
- SEC Form 4: Farrow Jeffrey S exercised 23,653 shares at a strike of $16.40, increasing direct ownership by 766% to 26,739 units4 - Global Blood Therapeutics, Inc. (0001629137) (Issuer)
- SEC Form 4: Habibizad Nazila exercised 29,755 shares at a strike of $19.17, increasing direct ownership by 251% to 41,623 units4 - Global Blood Therapeutics, Inc. (0001629137) (Issuer)
- SEC Form 4: Love Ted W gifted 256,500 shares, received a gift of 35,300 shares and exercised 18,291 shares at a strike of $16.40, decreasing direct ownership by 29% to 576,318 units4 - Global Blood Therapeutics, Inc. (0001629137) (Issuer)
- SEC Form 4: Choi Jung exercised 99,489 shares at a strike of $7.04 and gifted 73,855 shares, increasing direct ownership by 13% to 226,672 units4 - Global Blood Therapeutics, Inc. (0001629137) (Issuer)
- SEC Form 4: Smith-Whitley Kim converted options into 2,208 shares and covered exercise/tax liability with 607 shares, increasing direct ownership by 37% to 5,981 units to satisfy withholding obligation4 - Global Blood Therapeutics, Inc. (0001629137) (Issuer)
- SEC Form 4: Johnson David Lee was granted 365 shares, converted options into 4,971 shares and covered exercise/tax liability with 2,103 shares, increasing direct ownership by 6% to 56,384 units (withholding obligation)4 - Global Blood Therapeutics, Inc. (0001629137) (Issuer)
- SEC Form 4: Farrow Jeffrey S converted options into 4,971 shares, covered exercise/tax liability with 1,885 shares and sold $2,137,988 worth of shares (31,441 units at $68.00), decreasing direct ownership by 90% to 3,086 units to satisfy tax liability4 - Global Blood Therapeutics, Inc. (0001629137) (Issuer)
- SEC Form 4: Habibizad Nazila covered exercise/tax liability with 1,342 shares, was granted 414 shares and converted options into 3,878 shares, increasing direct ownership by 33% to 11,868 units (for withholding tax)4 - Global Blood Therapeutics, Inc. (0001629137) (Issuer)
- SEC Form 4: Suvari Tricia Borga was granted 385 shares, converted options into 4,971 shares and covered exercise/tax liability with 1,881 shares, increasing direct ownership by 9% to 43,077 units to satisfy withholding tax4 - Global Blood Therapeutics, Inc. (0001629137) (Issuer)
- SEC Form 4: Love Ted W converted options into 18,553 shares and covered exercise/tax liability with 9,200 shares, increasing direct ownership by 1% to 814,527 units (withholding tax)4 - Global Blood Therapeutics, Inc. (0001629137) (Issuer)
- SEC Form 4: Krehlik Carrie converted options into 10,268 shares and covered exercise/tax liability with 3,552 shares to cover taxes4 - Global Blood Therapeutics, Inc. (0001629137) (Issuer)
- SEC Form 4: Choi Jung converted options into 4,971 shares and covered exercise/tax liability with 1,861 shares, increasing direct ownership by 2% to 201,038 units to satisfy withholding obligation4 - Global Blood Therapeutics, Inc. (0001629137) (Issuer)
- SEC Form 4: Habibizad Nazila sold $314,315 worth of shares (4,678 units at $67.19), decreasing direct ownership by 34% to 8,918 units4 - Global Blood Therapeutics, Inc. (0001629137) (Issuer)
- SEC Form 4: Habibizad Nazila converted options into 1,518 shares and covered exercise/tax liability with 526 shares, increasing direct ownership by 8% to 13,596 units (tax liability)4 - Global Blood Therapeutics, Inc. (0001629137) (Issuer)
- SEC Form 4: Suvari Tricia Borga converted options into 6,145 shares and covered exercise/tax liability with 2,126 shares, increasing direct ownership by 11% to 39,602 units to cover taxes4 - Global Blood Therapeutics, Inc. (0001629137) (Issuer)
- SEC Form 4: Choi Jung converted options into 6,145 shares and covered exercise/tax liability with 2,126 shares, increasing direct ownership by 2% to 197,928 units (for withholding tax)4 - Global Blood Therapeutics, Inc. (0001629137) (Issuer)
- SEC Form 4: Love Ted W covered exercise/tax liability with 10,018 shares and converted options into 20,205 shares, increasing direct ownership by 1% to 805,174 units (for tax liability)4 - Global Blood Therapeutics, Inc. (0001629137) (Issuer)
- SEC Form 4: Farrow Jeffrey S covered exercise/tax liability with 2,126 shares and converted options into 6,145 shares, increasing direct ownership by 15% to 31,441 units (withholding tax)4 - Global Blood Therapeutics, Inc. (0001629137) (Issuer)
- SEC Form 4: Johnson David Lee converted options into 6,770 shares and covered exercise/tax liability with 2,342 shares, increasing direct ownership by 9% to 53,151 units to satisfy tax liability4 - Global Blood Therapeutics, Inc. (0001629137) (Issuer)
- SEC Form 3: New insider Habibizad Nazila claimed ownership of 10,528 shares (Amendment)3/A - Global Blood Therapeutics, Inc. (0001629137) (Issuer)
- SEC Form 4: Pizzo Philip A. sold $34,337 worth of shares (1,260 units at $27.25) as part of a pre-agreed trading plan, decreasing direct ownership by 12% to 9,112 units (tax liability)4 - Global Blood Therapeutics, Inc. (0001629137) (Issuer)
- SEC Form 4: Svoronos Dawn sold $51,983 worth of shares (1,908 units at $27.24) as part of a pre-agreed trading plan, decreasing direct ownership by 26% to 5,376 units to satisfy withholding tax4 - Global Blood Therapeutics, Inc. (0001629137) (Issuer)
- SEC Form 4: Perry Mark L converted options into 3,600 shares, increasing direct ownership by 11% to 37,865 units4 - Global Blood Therapeutics, Inc. (0001629137) (Issuer)
- SEC Form 4: Pizzo Philip A. converted options into 3,600 shares, increasing direct ownership by 53% to 10,372 units4 - Global Blood Therapeutics, Inc. (0001629137) (Issuer)
- SEC Form 4: Pierce Glenn converted options into 3,600 shares, increasing direct ownership by 16% to 26,437 units4 - Global Blood Therapeutics, Inc. (0001629137) (Issuer)
- SEC Form 4: Svoronos Dawn converted options into 3,600 shares, increasing direct ownership by 98% to 7,284 units4 - Global Blood Therapeutics, Inc. (0001629137) (Issuer)
- SEC Form 4: Thompson Alexis A. converted options into 908 shares, increasing direct ownership by 38% to 3,308 units4 - Global Blood Therapeutics, Inc. (0001629137) (Issuer)
- SEC Form 4: Morrison Scott W converted options into 3,600 shares, increasing direct ownership by 119% to 6,637 units4 - Global Blood Therapeutics, Inc. (0001629137) (Issuer)
- SEC Form 4: Yarno Wendy L converted options into 3,600 shares, increasing direct ownership by 46% to 11,437 units4 - Global Blood Therapeutics, Inc. (0001629137) (Issuer)
- SEC Form 4: Patrick Deval L converted options into 3,600 shares, increasing direct ownership by 66% to 9,037 units4 - Global Blood Therapeutics, Inc. (0001629137) (Issuer)
- SEC Form 4: Smith-Whitley Kim converted options into 6,040 shares and covered exercise/tax liability with 1,660 shares (for withholding tax)4 - Global Blood Therapeutics, Inc. (0001629137) (Issuer)
- SEC Form 4: Johnson David Lee converted options into 4,375 shares and covered exercise/tax liability with 1,513 shares, increasing direct ownership by 6% to 48,424 units (withholding tax)4 - Global Blood Therapeutics, Inc. (0001629137) (Issuer)
- SEC Form 4: Habibizad Nazila converted options into 1,558 shares and covered exercise/tax liability with 540 shares, increasing direct ownership by 4% to 30,036 units to cover taxes4 - Global Blood Therapeutics, Inc. (0001629137) (Issuer)
- SEC Form 4: Thompson Alexis A. converted options into 2,400 shares4 - Global Blood Therapeutics, Inc. (0001629137) (Issuer)
- SEC Form 4: Johnson David Lee covered exercise/tax liability with 956 shares, was granted 472 shares and converted options into 2,763 shares, increasing direct ownership by 5% to 45,562 units to cover taxes4 - Global Blood Therapeutics, Inc. (0001629137) (Issuer)
- SEC Form 4: Habibizad Nazila converted options into 1,671 shares and covered exercise/tax liability with 613 shares, increasing direct ownership by 4% to 29,018 units (withholding tax)4 - Global Blood Therapeutics, Inc. (0001629137) (Issuer)
- SEC Form 4: Suvari Tricia Borga was granted 453 shares, converted options into 2,763 shares and covered exercise/tax liability with 956 shares, increasing direct ownership by 7% to 35,653 units to cover taxes4 - Global Blood Therapeutics, Inc. (0001629137) (Issuer)
- SEC Form 4: Choi Jung converted options into 2,763 shares and covered exercise/tax liability with 956 shares, increasing direct ownership by 0.95% to 191,374 units to cover taxes4 - Global Blood Therapeutics, Inc. (0001629137) (Issuer)
- SEC Form 4 filed by Krehlik Carrie4 - Global Blood Therapeutics, Inc. (0001629137) (Issuer)
- SEC Form 4 filed by Smith-Whitley Kim4 - Global Blood Therapeutics, Inc. (0001629137) (Issuer)
- SEC Form 3: New insider Habibizad Nazila claimed ownership of 27,960 shares3 - Global Blood Therapeutics, Inc. (0001629137) (Issuer)
- SEC Form 4: Farrow Jeffrey S converted options into 2,763 shares and covered exercise/tax liability with 1,315 shares, increasing direct ownership by 6% to 27,422 units (withholding obligation)4 - Global Blood Therapeutics, Inc. (0001629137) (Issuer)
- SEC Form 4: Love Ted W covered exercise/tax liability with 4,074 shares, was granted 839 shares and converted options into 9,445 shares, increasing direct ownership by 0.79% to 794,987 units (for tax liability)4 - Global Blood Therapeutics, Inc. (0001629137) (Issuer)